Depending on your tax bracket, this effectively gives you a 22-32% discount on retatrutide costs
DOI: 10.1155/2023/9946924, Zheng, Z., Zong, Y., Ma, Y., et al
The three most likely pricing scenarios: Conservative ($1,200/month): Modest premium over tirzepatide, positions for market share capture
Faghris comprehensive research portfolio encompasses the study of occupational health and safety, examining workplace stressors and their impact on chronic diseases such as mental health issues, cardiovascular conditions, obesity, and type 2 diabetes
Sources Cited, not claimed
It's also more likely to cause side effects when taking higher doses